References
- Mowry JB, Spyker DA, Brooks DE, et al. 2015 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 33rd annual report. Clin Toxicol. 2016;54:924–1109.
- Sheridan DC, Hendrickson RG, Lin AL, et al. Adolescent suicidal ingestion: national trends over a decade. J Adolesc Health off Publ Soc Adolesc Med. 2017;60:191–195.
- Bushnell GA, Stürmer T, Swanson SA, et al. Dosing of selective serotonin reuptake inhibitors among children and adults before and after the FDA black-box warning. Psychiatr Serv. 2016;67:302–309.
- Rinke ML, Bundy DG, Shore AD, et al. Pediatric antidepressant medication errors in a national error reporting database. J Dev Behav Pediatr. 2010;31:129–136.
- Spiller HA, Ramoska EA, Krenzelok EP, et al. Bupropion overdose: a 3-year multi-center retrospective analysis. Am J Emerg Med. 1994;12:43–45.
- Mahajan P, Alpern ER, Grupp-Phelan J, et al. Epidemiology of psychiatric-related visits to emergency departments in a multicenter collaborative research pediatric network. Pediatr Emerg Care. 2009;25:715–720.
- Sheridan DC, Spiro DM, Fu R, et al. Mental health utilization in a pediatric emergency department. Pediatr Emerg Care. 2015;31:555–559.
- Hazell P, Mirzaie M. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev. 2013;18:CD002317.
- NPDS Coding Users’ Manual v 3.1. Medical Outcome. American Association of Poison Control Centers. May 2014:27–37.
- Schröder C, Dörks M, Kollhorst B, et al. Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011. Pharmacoepidemiol Drug Saf. 2017;26:170–179.
- Chee KY, Tripathi A, Avasthi A, et al. Prescribing pattern of antidepressants in children and adolescents: findings from the research on Asia psychotropic prescription pattern. East Asian Arch Psychiatry. 2016;26:10–17.
- Setlik J, Bond GR, Ho M. Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications. Pediatrics. 2009;124:875–880.
- Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387:2507–2520.
- Leischow SJ, Muramoto ML, Matthews E, et al. Adolescent smoking cessation with bupropion: the role of adherence. Nicotine Tob Res. 2016;18:1202–1205.
- Lewis JC, Sutter ME, Albertson TE, et al. An 11-year review of bupropion insufflation exposures in adults reported to the California Poison Control System. Clin Toxicol. 2014;52:969–972.
- Thorpe EL, Pizon AF, Lynch MJ, et al. Bupropion induced serotonin syndrome: a case report. J Med Toxicol. 2010;6:168–171.
- Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med. 2004;27:147–151.
- Finkelstein Y, Hutson JR, Freedman SB, Toxicology Investigators Consortium (ToxIC) Case Registry, et al. Drug-induced seizures in children and adolescents presenting for emergency care: current and emerging trends. Clin Toxicol. 2013;51:761–766.
- Starr P, Klein-Schwartz W, Spiller H, et al. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009;27:911–915.